Cambium Networks receives Nasdaq Staff Determination Letter; Will Seek Hearing & Continued Listing

Rhea-AI Summary

Cambium Networks (NASDAQ: CMBM) received a Nasdaq Staff Determination Letter dated October 10, 2025, notifying the company that its ordinary shares are subject to delisting from The Nasdaq Global Market.

The Staff found the company failed to maintain the $1.00 minimum bid price for 30 consecutive business days and did not regain compliance during the 180-calendar day cure period ending October 7, 2025. Separate deficiency notices cite delinquent SEC filings (2024 Form 10-K and 2025 Q1/Q2 10-Qs) with an extended cure deadline that the company could not meet.

The company will request a hearing before the Nasdaq Hearings Panel and may seek a stay; the Staff Determination Letter does not immediately suspend trading.

Positive

• Company will request a Nasdaq Hearings Panel hearing to contest delisting
• Requesting a hearing automatically stays suspension for 15 calendar days

Negative

• Nasdaq determined shares are subject to delisting for failing the $1.00 minimum bid price
• Company failed to regain compliance within the 180-calendar day cure period ended October 7, 2025
• Company has delinquent SEC filings (2024 Form 10-K and 2025 Q1/Q2 10-Qs) serving as a separate delisting basis

Insights

Listing & Compliance Analyst

Cambium faces Nasdaq delisting proceedings due to sub-$1 bid price and delinquent SEC filings; company will request a hearing and may seek a stay.

Nasdaq's Staff issued a formal determination on October 16, 2025 that the Company's Ordinary Shares are subject to delisting after the bid price failed the Minimum Bid Price Requirement for 30 consecutive business days and the Company did not regain compliance by October 7, 2025. Separately, the Company remains non‑compliant with the Nasdaq Filing Rule because its Annual Report on Form 10‑K for the year ended December 31, 2024 and Quarterly Reports on Form 10‑Q for the periods ended March 31, 2025 and June 30, 2025 are delinquent; the Staff had extended the filing deadline to October 13, 2025 and the Company acknowledged it could not comply by that date.

The Company intends to request a hearing before the Nasdaq Hearings Panel and can obtain an automatic 15‑day stay upon filing the hearing request; it may also request an extended stay, which the Hearings Panel will rule on within 15 days after the deadline to request the hearing. Key near‑term items to watch are whether the Company files the hearing request (which triggers the 15‑day automatic stay) and any subsequent Hearings Panel decision on an extended stay; these procedural steps will determine if trading suspension or delisting proceedings advance.

HOFFMAN ESTATES, Ill., Oct. 16, 2025 /PRNewswire/ -- Cambium Networks Corporation ("Cambium Networks" or the "Company") (NASDAQ: CMBM), a leading global provider of networking solutions, announced today that on October 10, 2025, it received a staff determination letter ("Staff Determination Letter") from the Listing Qualifications Department (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that the Company's Ordinary Shares are now subject to delisting from The Nasdaq Global Market.

As previously disclosed, the Company received a deficiency letter from the Staff on April 10, 2025 notifying the Company that, for 30 consecutive business days, the bid price for the Company's Ordinary Shares closed below the $1.00 per share minimum bid price requirement for continued inclusion on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement"). As the Company did not regain compliance with the Minimum Bid Price Requirement by October 7, 2025, the 180-calendar day grace period set forth by Listing Rule 5810(c)(3)(A), the Company's securities are now subject to delisting from The Nasdaq Global Market. The Staff Determination Letter has no immediate effect and will not immediately result in the suspension of trading or delisting of the Company's securities.

Additionally, as previously disclosed, the Company received deficiency letters from the Staff on April 16, 2025, May 22, 2025 and August 25, 2025 that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Filing Rule"), since the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2024 and its Quarterly Reports on Forms 10-Q for the periods ended March 31, 2025, and June 30, 2025, respectively (collectively, the "Delinquent Filings"), with the U.S. Securities and Exchange Commission (the "SEC"). The Staff had granted an extension of time until October 13, 2025 for the Company to regain compliance with the Filing Rule. On September 9, 2025, the Company notified the Staff that it would not be able to regain compliance with the Filing Rule by October 13, 2025. Pursuant to Listing Rule 5810(c)(2), these Delinquent Filings serve as a separate and additional bases for delisting.

Accordingly, and as described in the Staff Determination Letter, the Company intends to timely request a hearing before the Nasdaq Hearings Panel (the "Hearings Panel") with regard to the Minimum Bid Price Requirement and the Delinquent Filings, pursuant to the procedures as set forth in the Nasdaq Listing Rule 5800 Series. A request for a hearing regarding one or more delinquent filings will automatically stay the suspension of the Company's securities for a period of 15 calendar days from the date of the hearing request. When the Company requests a hearing, it may also request a stay of the suspension, pending the hearing.

A Hearings Panel will review the request for an extended stay and notify the Company of its conclusion no later than 15 days following the deadline to request the hearing. There can be no assurance that the Hearings Panel will grant any of the Company's requests for additional time. In the unlikely event that Nasdaq is not able to rule on the stay of a suspension prior to the expiration of the automatic stay, it has been Nasdaq's practice to take no action until a Hearings Panel is able to make a ruling on the extended stay request. Once the Hearings Panel makes a ruling on the extended stay, the Company intends to make a subsequent announcement.

About Cambium Networks

Cambium Networks enables service providers, enterprises, industrial organizations, and governments to deliver exceptional digital experiences, and device connectivity, with compelling economics. Our ONE Network platform simplifies management of Cambium Networks' wired and wireless broadband and network edge technologies. Our customers can focus more resources on managing their business rather than the network. We make connectivity that just works.

Forward-Looking Statements

This press release contains forward-looking statements, including, but not limited to, words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," "seeks," "assumes," "may," "should," "could," "would," and variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based upon the Company's current assumptions, beliefs, and expectations. Forward-looking statements are subject to the occurrence of many events outside of the Company's control. Actual results and the timing of events may differ materially from those contemplated by such forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things, the Company's ability to return to and maintain compliance with Nasdaq continued listing standards and whether Nasdaq will grant the Company any relief from delisting. Forward-looking statements should be considered in light of these risks and uncertainties. Investors and others are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained herein speak only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Contacts: 
Investor Relations
Cambium Networks
investors@cambiumnetworks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cambium-networks-receives-nasdaq-staff-determination-letter-will-seek-hearing--continued-listing-302586672.html

SOURCE Cambium Networks

FAQ

What did Nasdaq notify Cambium Networks (CMBM) on October 10, 2025?

Nasdaq issued a Staff Determination Letter notifying Cambium that its shares are subject to delisting from The Nasdaq Global Market.

Why is CMBM subject to delisting for the minimum bid price?

CMBM's bid price closed below the $1.00 minimum for 30 consecutive business days and did not regain compliance during the 180-calendar day cure period that ended October 7, 2025.

Which SEC filings are delinquent for Cambium Networks (CMBM)?

The company has not filed its 2024 Form 10-K and its 2025 Q1 and Q2 Forms 10-Q, which Nasdaq cited as a separate delisting basis.

Will trading in CMBM be suspended immediately after the Staff Determination Letter?

No. The Staff Determination Letter has no immediate effect and will not immediately suspend trading or delist the securities.

What immediate procedural step will Cambium Networks (CMBM) take after the determination?

The company intends to timely request a hearing before the Nasdaq Hearings Panel and may request an extended stay of suspension.

How long does the automatic stay last when CMBM requests a hearing?

A hearing request automatically stays suspension for 15 calendar days from the date of the request.

Is there assurance Nasdaq will grant additional time to CMBM?

There can be no assurance the Hearings Panel will grant the company any requested additional time.